Finfeed Archived Feb 01, 2021
Creso Pharma (ASX: CPH) is prepared to meet demand as OTC sales of low-dose cannabidiol products start in Australian pharmacies.
Finfeed Archived Dec 15, 2020
Creso Pharma (ASX: CPH) is positioned to significantly benefit from a TGA decision to down-schedule low dose CBD preparations.
Get expert stock analysis direct in your inbox
Join OurMailing List
